| # | Drug | Count |
|---|---|---|
| 0 | TREPROSTINIL | 40 |
| 1 | MACITENTAN | 24 |
| 2 | AMBRISENTAN | 18 |
| 3 | TADALAFIL | 18 |
| 4 | SILDENAFIL CITRATE | 14 |
| 5 | SELEXIPAG | 13 |
| 6 | 0XYGEN | 10 |
| 7 | OXYGEN | 10 |
| 8 | FUROSEMIDE | 9 |
| 9 | POTASSIUM CHLORIDE | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | METHENAMINE MANDELATE | 1 | 0.0053 |
| 1 | DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS | 1 | 0.0026 |
| 2 | ECONAZOLE NITRATE | 2 | 0.0021 |
| 3 | PROTHROMBIN, COAGULATION FACTOR VII HUMAN, COAGULATION FACTOR IX HUMAN, COAGULATION FACTOR X HUMAN, PROTEIN C, PROTEIN S HUMAN, AND WATER | 1 | 0.0018 |
| 4 | PROTAMINE SULFATE | 2 | 0.0011 |
| 5 | MARALIXIBAT CHLORIDE | 1 | 0.0010 |
| 6 | AMMONIUM LACTATE | 2 | 0.0009 |
| 7 | OMADACYCLINE | 1 | 0.0006 |
| 8 | SELEXIPAG | 13 | 0.0005 |
| 9 | MIDODRINE HYDROCHLORIDE | 2 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Prostacycline Vasodilator [EPC] | 43 |
| 1 | Endothelin Receptor Antagonist [EPC] | 39 |
| 2 | Phosphodiesterase 5 Inhibitor [EPC] | 22 |
| 3 | Prostacyclin Receptor Agonist [EPC] | 13 |
| 4 | Loop Diuretic [EPC] | 12 |
| 5 | Osmotic Laxative [EPC] | 11 |
| 6 | Factor Xa Inhibitor [EPC] | 10 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 10 |
| 8 | Potassium Salt [EPC] | 8 |
| 9 | Provitamin D2 Compound [EPC] | 8 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | alpha-Hydroxy Acid [EPC] | 2 | 0.0009 |
| 2 | Prostacyclin Receptor Agonist [EPC] | 13 | 0.0005 |
| 3 | Prostacycline Vasodilator [EPC] | 43 | 0.0003 |
| 4 | Provitamin D2 Compound [EPC] | 8 | 0.0003 |
| 5 | Soluble Guanylate Cyclase Stimulator [EPC] | 8 | 0.0002 |
| 6 | Endothelin Receptor Antagonist [EPC] | 39 | 0.0002 |
| 7 | Phosphodiesterase 5 Inhibitor [EPC] | 22 | 0.0002 |
| 8 | Tetracycline-class Antibacterial [EPC] | 1 | 0.0001 |
| 9 | Chloride Channel Activator [EPC] | 1 | 0.0001 |